Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3298-3307

  Henriquez, Nico V ^a   Floettmann, Eike ^b   Salmon, Mike ^a   Rowe, Martin ^b   Rickinson, Alan B ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; FAS ANTIGEN; GLYCOPROTEIN GP 39; HLA ANTIGEN CLASS 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LATENT MEMBRANE PROTEIN 1; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL AGGREGATION; CELL SURFACE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GROWTH INHIBITION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL;

ANTIGENS, CD40; ANTIGENS, CD95; BURKITT LYMPHOMA; CD40 LIGAND; CELL AGGREGATION; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HERPESVIRUS 4, HUMAN; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LIGANDS; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; TRANSFECTION; TUMOR CELLS, CULTURED; UP-REGULATION; VIRAL MATRIX PROTEINS;

EID: 0033559896     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. van Kooten, C., and J. Banchereau. 1997. Functions of CD40 on B cells, dendritic cells and other cells. Curr. Opin. Immunol. 9:330.
2. Hess, S., A. Rensing-Ehl, R. Schwabe, P. Bufler, and H. Engelmann 1995, CD40 function in nonhematopoietic cells: nuclear factor κB mobilization and induction of IL-6 production. J. Immunol. 155:4588.
3. Gray, D. 1997. CD40 signalling in T-dependent B cell responses. In Lymphocyte Signalling: Mechanisms, Subversion and Manipulation. H. M. Harnett and K. P. Rigley, eds. John Wiley and Sons, Chichester, p. 77.
4. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424.
5. Cheng, G., A. M. Cleary, Z. S. Ye, D. I. Hong, S. Lederman, and D. Baltimore. 1995. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267:1494.
6. Ishida, T. K., T. Tojo, T. Aoki, N. Kobayashi, T. Ohisbi, T. Watanabe, T. Yamamoto, and J. Inoue. 1996. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling. Proc. Natl. Acad. Sci. USA 93:9437.
7. Ishida, T., S. Mizushima, S. Azuma, N. Kobayashi, T. Tojo, K. Suzuki, S. Aizawa, T. Watanabe, G. Mosialos, E. Kieff, et al. 1996. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271:28745.
8. MacLennan, I. C. 1994. Germinal centers. Annu. Rev. Immunol. 12:117.
9. Rathmell, J. C., S. E. Townsend, J. C. Xu, R. A. Flavell, and C. C. Goodnow. 1996. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. Cell 87:319.
10. Allen, R. C., R. J. Armitage, M. E. Conley, H. Rosenblatt, N. A. Jenkins, N. G. Copeland, M. A. Bedell, S. Edelhoff, C. M. Disteche, D. K. Simoneaux, et al. 1993. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990.
11. Nonoyama, S., D. Hollenbaugh, A. Aruffo, J. A. Ledbetter, and H. D. Ochs. 1993. B cell activation via CD40 is required for specific antibody production by antigen-stimulated human B cells. J. Exp. Med. 178:1097.
12. Arpin, C., J. Dechanet, C. van Kooten, P. Merville, G. Grouard, F. Briere, J. Banchereau, and Y. Liu. 1995. Generation of memory B cells and plasma cells in vitro. Science 268:720.
13. Barrett, T. B., G. Shu, and E. A. Clark. 1991. CD40 signaling activates CD11a/ CD18 (LFA-1)-mediated adhesion in B cells. J. Immunol. 146:1722.
14. Burlinson, E. L., P. Graber, J. Y. Bonnefoy, B. W. Ozanne, and W. Cushley. 1996. Soluble CD40 ligand induces expression of CD25 and CD23 in resting human tonsillar B lymphocytes. Eur. J. Immunol. 26:1069.
15. Schattner, E. J., K. B. Elkon, D. H. Yoo, J. Tumang, P. H. Krammer, M. K. Crow, and S. M. Friedman. 1995. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182:1557.
16. Defrance, T., B. Vanbervliet, F. Briere, I. Durand, F. Rousset, and J. Banchereau. 1992. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175:671.
17. Shapira, S. K., D. Vercelli, H. H. Jabara, S. M. Fu, and R. S. Geha. 1992. Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J. Exp. Med. 175:289.
18. Gray, D., K. Siepmann, and G. Wohlleben. 1994. CD40 ligation in B cell activation, isotype switching and memory development. Semin. Immunol. 6:303.
19. Koopman, G., R. M. Keehnen, E. Lindhout, D. F. Zhou, C. de Groot, and S. T. Pals. 1997. Germinal center B cells rescued from apoptosis by CD40 ligation or attachment to follicular dendritic cells, but not by engagement of surface immunoglobulin or adhesion receptors, become resistant to CD95-induced apoptosis. Eur. J. Immunol. 27:1.
20. Galibert, L., N. Burdin, B. de Saint-Vis, P. Garrone, C. van Kooten, J. Banchereau, and R. Rousset. 1996. CD40 and B cell antigen receptor dual triggering of resting B lymphocytes turns on a partial germinal center phenotype. J. Exp. Med. 183:77.
21. Holder, M. J., H. Wang, A. E. Milner, M. Casamayor, R. Armitage, M. K. Spriggs, W. C. Fanslow, I. C. MacLennan, C. D. Gregory, and J. Gordon. 1993. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur. J. Immunol. 23:2368.
22. Knox, K. A., M. Finney, A. E. Milner, C. D. Gregory, M. J. Wakelam, R. H. Michell, and J. Gordon. 1992. Second-messenger pathways involved in the regulation of survival in germinal-centre B cells and in Burkitt lymphoma lines. Int. J. Cancer 52:959.
23. Sumimoto, S., T. Heike, S. Kanazashi, N. Shintaku, E. Y. Jung, D. Hata, K. Katamura, and M. Mayumi. 1994. Involvement of LFA-1/intracellular adhesion molecule-1-dependent cell adhesion in CD40-mediated inhibition of human B lymphoma cell death induced by surface IgM crosslinking. J. Immunol. 153: 2488.
24. Khanna, R., L. Cooper, N. Kienzle, D. J. Moss, S. R. Burrows, and K. K. Khanna. 1997. Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells. J. Immunol. 159:5782.
25. MacDonald, I., H. Wang, R. Grand, R. J. Armitage, W. C. Fanslow, C. D. Gregory, and J. Gordon. 1996. Transforming growth factor-β1 cooperates with anti-immunoglobulin for the induction of apoptosis in group 1 (biopsy-like) Burkitt lymphoma cell lines. Blood 87:1147.
26. An, S., and K. A. Knox. 1996. Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cysteine protease CPP32/Yama and cleavage of its substrate PARP. FEBS Lett. 386:115.
27. Wang, H., R. J. Grand, A. E. Milner, R. J. Armitage, J. Gordon, and C. D. Gregory. 1996. Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein. Oncogene 13:373.
28. Sarma, V., Z. Lin, L. Clark, B. M. Rust, M. Tewari, R. J. Noelle, and V. M. Dixit. 1995. Activation of the B-cell surface receptor CD40 induces A20, a novel zinc finger protein that inhibits apoptosis. J. Biol. Chem. 270:12343.
29. Funakoshi, S., D. L. Longo, M. Beckwith, D. K. Conley, G. Tsarfaty, I. Tsarfaty, R. J. Armitage, W. C. Fanslow, M. K. Spriggs, and W. J. Murphy. 1994. Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood 83:2787.
30. Bergman, M. C., J. F. Attrep, A. C. Grammer, and P. E. Lipsky. 1996. Ligation of CD40 influences the function of human Ig-secreting B cell hybridomas both positively and negatively. J. Immunol. 156:3118.
31. Heath, A. W., R. Chang, N. Harada, L. Santos-Argumedo, J. Gordon, C. Hannum, D. Campbell, A. B. Shanafelt, E. A. Clark, R. Torres, et al. 1993. Antibodies to murine CD40 stimulate normal B lymphocytes but inhibit proliferation of B lymphoma cells. Cell. Immunol. 152:468.
32. Peng, M., and E. Lundgren. 1993. Transient expression of the Epstein-Barr virus LMP1 gene in B-cell chronic lymphocytic leukemia cells. T cells, and hematopoietic cell lines: cell-type-independent-induction of CD23, CD21, and ICAM-1. Leukemia 7:104.
33. Rowe, M., R. Khanna, C. A. Jacob, V. Argaet, A. Kelly, S. Powis, M. Belich, D. Croom-Carter, S. Lee, S. R. Burrows, et al. 1995. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: co-ordinate up-regulation of peptide transporters and HLA class 1 antigen expression. Eur. J. Immunol. 25:1374.
34. Henderson, S., M. Rowe, C. Gregory, D. Croom-Carter, F. Wang, R. Longnecker, E. Kieff, and A. Rickinson. 1991. Induction of Bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65:1107.
35. Rowe, M., M. Peng-Pilon, D.S. Huen, R. Hardy, D. Croom-Carter, E. Lundgren, and A. B. Rickinson. 1994. Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-κB activation and to induction of cell surface markers. J. Virol. 68:5602.
36. Laherty, C. D., H. M. Hu, A. W. Opipari, F. Wang, and V. Dixit. 1992. The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating NF-κB. J. Biol. Chem. 267:24157.
37. Huen, D. S., S. A. Henderson, D. Croom-Carter, and M. Rowe. 1995. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549.
38. Devergne, O., E. Hatzivassiliou, K. M. Izumi, K. M. Kaye, M. F. Kleijnen, E. Kieff, and G. Mosialos. 1996. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol. 16:7098.
39. Floettmann, J. E., K. Ward, A. B. Rickinson, and M. Rowe. 1996. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracyeline-regulated expression in B cell lines. Virology 223:29.
40. Rowe, M., D. T. Rowe, C.D. Gregory, L. S. Young, P. J. Farrell, H. Rupani, and A. B. Rickinson. 1987. Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J. 6:2743.
41. Beiske, K., E. A. Clark, H. Holte, J. A. Ledbetter, E. B. Smeland, and T. Godal. 1988. Triggering of neoplastic B cells via surface IgM and the cell surface antigens CD20 and CDw40: responses differ from normal blood B cells and are restricted to certain morphologic subsets. Int. J. Cancer 42:521.
42. Banchereau, J., P. De Paoli, A. Valle, E. Garcia, and F. Roussel, 1991. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70.
43. Eliopoulos, A. G., M. Stack, C. W. Dawson, K. M. Kaye, L. Hodgkin, S. Sihota, M. Rowe, and L. S. Young. 1997. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-κB pathway involving TNF receptor-associated factors. Oncogene 14:2899.
44. Eliopoulos, A. G., C. W. Dawson, G. Mosialos, J. E. Floettmann, M. Rowe, R. J. Armitage, J. Dawson, J. M. Zapala, D. J. Ken, M. J. Wakelam, et al. 1996. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene 13:2243.
45. Bjorck, P., and S. Paulie S. 1996. CD40 antibodies defining distinct epitopes display qualitative differences in their induction of B-cell differentiation Immunology 87:291.
46. Arenzana-Seisdedos, F., B. Fernandez, I. Dominguez, J. M. Jacque, D. Thomas, M. T. Diaz-Meco, J. Moscat, and J. L. Virelizier. 1993. Phosphatidylcholine hydrolysis activates NF-κB and increases human immunodeficiency virus replication in human monocytes and T lymphocytes. J. Virol. 67:6596.
47. Rickinson, A. B., and E. Kieff. 1996. Epstein-Barr virus. In Fields' Virology, B. N. Fields, D. M. Knipe, and P. M. Howley, eds. Raven Press New York, p. 2397.
48. de Fougerolles, A. R., and T. A. Springer. 1992. Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes. J. Exp. Med. 175:185.
49. Cheng, J., C. Liu, W. J. Koopman, and J. D. Mountz. 1995. Characterization of human Fas gene: exon/intron organization and promoter region. J. Immunol. 154-1239.
50. Floettmann, J. E., and M. Rowe. 1997. Epstein-Barr virus latent membrane protein-1 (LMP1) C-terminus activation region 2 (CTAR2) maps to the far C-terminus and requires oligomerisation for NF-κB activation. Oncogene 15:1851.
51. Izumi, K. M., and E. D. Kieff. 1997. The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB. Proc. Natl. Acad. Sci. USA 94:12592.